← SynDRA
Beta-funaltrexamine
SynDRA canonical compound SYN1968282 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | OPRD1 | OPRK1 | OPRM1 |
|---|
| Mechanism of action | opioid receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- opioid receptor antagonist
Cross-references
Synonyms
- Beta Funaltrexamine
- beta-Fna
- Naltrexone fumarate methyl ester
- CHEMBL473136
- CHEBI:81527
- 2-Butenoic acid, 4-(((5alpha,6beta)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl)amino)-4-oxo-, methyl ester, (E)-
- Beta-Funeltrexamine
- SCHEMBL1240811
- GTPL1631
- ZINC3995756
- PDSP2_001549
- PDSP2_000394
- BDBM50247803
- NCGC00163180-01
- LS-47116
- C18127
- methyl 3-[4-cyclopropylmethyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-ylcarbamoyl]-
Look up Beta-funaltrexamine in the interactive SynDRA portal →